{"id":"benzamidosalicylate","rwe":[{"pmid":"2722","year":"1975","title":"Proceedings: Bacterial degradation of calcium benzamidosalicylate.","finding":"","journal":"The Journal of pharmacy and pharmacology","studyType":"Clinical Study"},{"pmid":"5865665","year":"1965","title":"[Calcium benzamidosalicylate. (Calc. benzamidosalicyl.)].","finding":"","journal":"Ceskoslovenska farmacie","studyType":"Clinical Study"},{"pmid":"13817982","year":"1959","title":"4-Aminosalicylic acid blood levels following oral administration of sodium 4-aminosalicylate and calcium 4-benzamidosalicylate.","finding":"","journal":"Tubercle","studyType":"Clinical Study"}],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"bepascum","offLabel":[],"synonyms":["benzamidosalicylate","calcium benzamidosalicylate","calcium benzoylas","bepascum"],"timeline":[],"brandName":"Bepascum","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Imagine your body's cells are like locks, and Bepascum is a key that fits into one of those locks. When it binds to the lock, it triggers a series of events that ultimately lead to the desired therapeutic outcome. This process is known as a pharmacological interaction.","oneSentence":"Bepascum works by interacting with a specific molecular target to produce a therapeutic effect.","technicalDetail":"Bepascum's mechanism of action is not well understood, but it is believed to involve the inhibition of a specific enzyme or receptor, leading to changes in cellular signaling pathways and ultimately resulting in its therapeutic effects."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/327","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=benzamidosalicylate","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T08:56:13.232797","biosimilars":[],"competitors":[],"genericName":"benzamidosalicylate","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"595178KF31","CHEBI":"CHEBI:135059","INN_ID":"893","UMLSCUI":"C5238139","ChEMBL_ID":"CHEMBL1487804","PUBCHEM_CID":"10718"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":3,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[{"date":"1975 Dec","pmid":"2722","title":"Proceedings: Bacterial degradation of calcium benzamidosalicylate.","journal":"The Journal of pharmacy and pharmacology"},{"date":"1965 Dec","pmid":"5865665","title":"[Calcium benzamidosalicylate. (Calc. benzamidosalicyl.)].","journal":"Ceskoslovenska farmacie"},{"date":"1959 Jun","pmid":"13817982","title":"4-Aminosalicylic acid blood levels following oral administration of sodium 4-aminosalicylate and calcium 4-benzamidosalicylate.","journal":"Tubercle"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Bepascum is a small molecule with the synonyms BENZAMIDOSALICYLATE, NSC-159686, and NSC-759125.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}